We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Federal Circuit Denies Ariad's Request

Law360 (January 5, 2007, 12:00 AM EST) -- In yet another setback for Ariad Pharmaceuticals Inc., a federal appeals court has rejected the drug maker’s request to hear an early appeal of a pretrial ruling in the patent infringement suit filed by rival Amgen Inc.

With its decision, the U.S. Court of Appeals for the Federal Circuit ensured the biotech dispute will head to trial in the U.S. District Court for the District of Delaware, where Amgen sued in April to invalidate Ariad’s patent.

Amgen is seeking a declaratory judgment that Ariad’s heavily litigated...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.